Structure-Based Drug Design Strategies in Medicinal Chemistry

被引:124
作者
Andricopulo, Adriano D. [1 ]
Salum, Livia B. [1 ]
Abraham, Donald J. [2 ]
机构
[1] Univ Sao Paulo, Inst Fis Sao Carlos, Ctr Biotecnol Mol Estrutural, Lab Quim Med & Computac, BR-13560970 Sao Carlos, SP, Brazil
[2] Virginia Commonwealth Univ, Inst Struct Biol & Drug Discovery, Sch Pharm, Dept Med Chem, Richmond, VA 23284 USA
基金
巴西圣保罗研究基金会;
关键词
Structure-based drug design; medicinal chemistry; virtual screening; QSAR; pharmacophores; STRUCTURE-BASED OPTIMIZATION; STRUCTURE-BASED DISCOVERY; PROTEIN-LIGAND COMPLEXES; MOLECULAR-FIELD ANALYSIS; HUMAN CARBONIC-ANHYDRASE; FRAGMENT-BASED QSAR; LEAD OPTIMIZATION; FLEXIBLE DOCKING; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; PHARMACOPHORE MODEL;
D O I
10.2174/156802609789207127
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A broad variety of medicinal chemistry approaches can be used for the identification of hits, generation of leads, as well as to accelerate the development of high quality drug candidates. Structure-based drug design (SBDD) methods are becoming increasingly powerful, versatile and more widely used. This review summarizes current developments in structure-based virtual screening and receptor-based pharmacophores, highlighting achievements as well as challenges, along with the value of structure-based lead optimization, with emphasis on recent examples of successful applications for the identification of novel active compounds.
引用
收藏
页码:771 / 790
页数:20
相关论文
共 137 条
[1]   Receptor flexibility in de novo ligand design and docking [J].
Alberts, IL ;
Todorov, NP ;
Dean, PM .
JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (21) :6585-6596
[2]   The process of structure-based drug design [J].
Anderson, AC .
CHEMISTRY & BIOLOGY, 2003, 10 (09) :787-797
[3]   Three-dimensional quantitative structure-activity relationships for a large series of potent antitubercular agents [J].
Andrade, Carolina Horta ;
Salum, Livia de Barros ;
Mesquita Pasqualoto, Kerly Fernanda ;
Ferreira, Elizabeth Igne ;
Andricopulo, Adriano Defini .
LETTERS IN DRUG DESIGN & DISCOVERY, 2008, 5 (06) :377-387
[4]   Specific inhibitors of Plasmodium falciparum thioredoxin reductase as potential antimalarial agents [J].
Andricopulo, AD ;
Akoachere, MB ;
Krogh, R ;
Nickel, C ;
McLeish, MJ ;
Kenyon, GL ;
Arscott, LD ;
Williams, CH ;
Davioud-Charvet, E ;
Becker, K .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (08) :2283-2292
[5]   Structure-activity relationships for the design of small-molecule inhibitors [J].
Andricopulo, AD ;
Montanari, CA .
MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2005, 5 (06) :585-593
[6]   Computational models for predicting interactions with cytochrome p450 enzyme [J].
Arimoto, Rieko .
CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2006, 6 (15) :1609-1618
[7]   BCX-1812 (RWJ-270201): Discovery of a novel, highly potent, orally active, and selective influenza neuraminidase inhibitor through structure-based drug design [J].
Babu, YS ;
Chand, P ;
Bantia, S ;
Kotian, P ;
Dehghani, A ;
El-Kattan, Y ;
Lin, TH ;
Hutchison, TL ;
Elliott, AJ ;
Parker, CD ;
Ananth, SL ;
Horn, LL ;
Laver, GW ;
Montgomery, JA .
JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (19) :3482-3486
[8]   Integration of virtual and high-throughput screening [J].
Bajorath, F .
NATURE REVIEWS DRUG DISCOVERY, 2002, 1 (11) :882-894
[9]   Characterization of an inhibitory dynamic pharmacophore for the ERCC1-XPA interaction using a combined molecular dynamics and virtual screening approach [J].
Barakat, Khaled H. ;
Huzil, J. Torin ;
Luchko, Tyler ;
Jordheim, Lars ;
Dumontet, Charles ;
Tuszynski, Jack .
JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 2009, 28 (02) :113-139
[10]   GENERATING OPTIMAL LINEAR PLS ESTIMATIONS (GOLPE) - AN ADVANCED CHEMOMETRIC TOOL FOR HANDLING 3D-QSAR PROBLEMS [J].
BARONI, M ;
COSTANTINO, G ;
CRUCIANI, G ;
RIGANELLI, D ;
VALIGI, R ;
CLEMENTI, S .
QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIPS, 1993, 12 (01) :9-20